Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2022-2030

GLOBAL CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2022-2030

In terms of revenue, the global cardiovascular ultrasound market was valued at $1477.29 million in 2021, and is expected to reach $2472.64 million by 2030, growing at a CAGR of 5.90% during the forecast period. The market study has also analyzed the impact of COVID-19 on the cardiovascular ultrasound industry qualitatively as well as quantitatively.

GLOBAL CARDIOVASCULAR ULTRASOUND MARKET FORECAST 2022-2030

Global Cardiovascular Ultrasound Market by Display (Black and White, Color) Market by Technology (2D, 3D/4D, Doppler) Market by Type (Transthoracic Echocardiography, Fetal Echocardiography, Transesophageal Echocardiography, Other Types) Market by End-user (Hospitals, Diagnostic Centers, Ambulatory Care Centers, Other End-users) by Geography

Request free sample

In terms of revenue, the global cardiovascular ultrasound market was valued at $1477.29 million in 2021, and is expected to reach $2472.64 million by 2030, growing at a CAGR of 5.90% during the forecast period. The market study has also analyzed the impact of COVID-19 on the cardiovascular ultrasound industry qualitatively as well as quantitatively.

To know more about this report, request a free sample copy

Cardiac ultrasound, also known as echocardiography, is a non-invasive diagnostic modality that can provide detailed hemodynamic information about the heart in a relatively short period. Cardiologists used it for diagnostic purposes in the 1960s, and emergency doctors used it as one of several point-of-care ultrasound applications from head to toe. Transthoracic echocardiography, fetal echocardiography, transesophageal echocardiography, and other procedures use cardiovascular ultrasound.

Cardiovascular Ultrasound Market

Read our latest blog on the Cardiovascular Ultrasound Market

Key enablers of the global cardiovascular ultrasound market growth are:

  • Rising cardiovascular diseases
    • Cardiovascular diseases have surpassed cancer as the leading cause of death worldwide. Heart attacks and strokes account for 85% of all cardiovascular disease-related deaths every year, affecting 17.9 million people worldwide. In addition, cardiovascular diseases accounted for approximately 19.05 million deaths globally in 2020.
    • There are several risk factors for heart disease, the primary ones being consuming alcohol, tobacco, an unhealthy diet, and physical inactivity. Certain side-effects of these risk factors are observed in individuals. These include obesity and high blood pressure.
  • Technological advancements

Key growth restraining factors are:

  • Lack of awareness among patients
  • Stringent regulations
    • If medically appropriate, the FDA recommends that health care providers consider examinations with little or no ionizing radiation exposure, such as ultrasound.
    • Regulatory policies and approval procedures for ultrasound devices vary across regions and countries. As a result, product launches in various geographic locations are delayed.

Global Cardiovascular Ultrasound Market | Top Trends

  • The use of artificial intelligence (AI) in cardiovascular ultrasound has made the procedure more efficient in terms of cost reduction and avoiding unnecessary testing. Artificial intelligence in echocardiography is useful for recognizing the standard section, automatic segmentation of the cardiac cavity, functional left ventricle assessment, and cardiac disease diagnosis.
  • Strain imaging is a technique used in cardiac imaging to detect ventricular deformation patterns and functional abnormalities. It has recently seen a slow but steady increase due to technological advancements. Cardiovascular ultrasound and cardiac magnetic resonance are used for strain imaging.
  • Point-of-Care Ultrasound (POCUS) is a portable ultrasound system that allows patients to be assessed without having to be physically present in the cardiology department. Given its capabilities, many clinicians prefer POCUS as a supplement to physical examination. Technology has advanced to the point where practitioners can quickly make informed decisions about patient care management and diagnoses, regardless of the patient’s location.
  • Fetal echocardiography can also detect heart defects before birth. It is becoming more popular and will be used more frequently in clinics, hospitals, and other locations.

Market Segmentation – Display, Technology, Type, and End-User –

Market by Display:

  • Black and White
  • Color

Market by Technology:

  • 2D
  • 3D/4D
  • Doppler
    • Doppler is the fastest growing technology in the cardiovascular ultrasound market, with a CAGR of 6.65%.
    • Doppler technology is used to measure and assess blood flow through the chambers and valves of the heart. It can also detect any irregularities in blood flow within the heart. At the same time, doppler-based ultrasound technology can detect heart valve defects, congenital heart disease, blocked arteries, bulging arteries, and so on. Doppler technology also aids in determining how quickly blood can flow.

Market by Type:

  • Transthoracic Echocardiography
    • Transthoracic echocardiography has emerged as the largest revenue-generating type in the global market, with a 55.47% revenue share in 2021.
    • Transthoracic echocardiography has become the most important non-invasive screening tool for pulmonary hypertension due to its wide availability, low cost, and safety in repeated use without exposing the patient to ionizing radiation.
  • Fetal Echocardiography
  • Transesophageal Echocardiography
  • Other Types

Market by End-User:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Other End-Users

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
    • North America is the dominating region, with a 28.91% market share in 2021, attributed to deaths caused by heart disease in the United States. For instance, approximately 6,59,000 Americans are killed annually by heart disease in the United States.
    • Further, around 2.4 million Canadians are affected by heart disease. It is the second leading cause of death in Canada. Heart disease, stroke, or vascular cognitive impairment account for more than one out of every ten hospitalizations in Canada. Previously, fewer people were admitted to hospitals for cardiovascular diseases. However, the number of people admitted for these conditions is increasing.
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Taiwan, Singapore, Australia & New Zealand, and Rest of Asia-Pacific
    • Asia-Pacific is the fastest-growing region in the global market, set to record a CAGR of 6.61%. The market is expanding due to the increasing number of cardiovascular diseases, Asia’s leading cause of death.
    • Furthermore, artificial intelligence positively impacts cardiology by providing advanced diagnostic capabilities for certain heart conditions.
    • Besides, there is a high demand for portable ultrasound, given the region’s increased preference for minimally invasive surgeries.
    • Moreover, the Chinese cardiovascular ultrasound market is rapidly expanding as new companies enter the Chinese market, such as Viatom Technologies and Lanmage.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global cardiovascular ultrasound market are:

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Samsung Medison Co Ltd
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation

Key strategies adopted by some of these companies:

  • FUJIFILM has strong research and developments (R&D) capabilities. The company has been regularly strengthening its R&D domain.
  • In March 2022, at the American College of Cardiology’s Annual Scientific Session & Expo, Philips Healthcare introduced Ultrasound Workspace (ACC 2022).
  • In September 2021, Philips Healthcare and Main Line Health’s Lankenau Heart Institute announced a five-year strategic partnership focused on integrated cardiovascular solutions.
  • In August 2021, Leltek announced that its LU710 series have been approved by the Taiwan Food and Drug Administration and is now available in Taiwan.

Report Synopsis:

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Display, Technology, Type, End-User
Geographies Analyzed North America, Europe, Asia-Pacific, Rest of World
Companies Analyzed

Canon Medical Systems Corporation, Clarius, Dawei Medical, Esaote SpA, Fujifilm Holdings Corporation, GE Healthcare, Lanmage, Leltek, Mindray Medical International Limited, Philips Healthcare, Samsung Medison Co Ltd, Siemens Healthineers, Telemed Ultrasound Medical Systems, Viatom Technology Co, Zoncare

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • RISING CARDIOVASCULAR DISEASES
      • TECHNOLOGICAL ADVANCEMENTS
    • KEY RESTRAINTS
      • LACK OF AWARENESS AMONG PATIENTS
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON CARDIOVASCULAR ULTRASOUND MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • QUALITY
      • DURABILITY
      • PRICE
      • TECHNOLOGY
    • REGULATORY FRAMEWORK
  2. MARKET BY DISPLAY
    • BLACK AND WHITE
    • COLOR
  3. MARKET BY TECHNOLOGY
    • 2D
    • 3D/4D
    • DOPPLER
  4. MARKET BY TYPE
    • TRANSTHORACIC ECHOCARDIOGRAPHY
    • FETAL ECHOCARDIOGRAPHY
    • TRANSESOPHAGEAL ECHOCARDIOGRAPHY
    • OTHER TYPES
  5. MARKET BY END-USER
    • HOSPITALS
    • DIAGNOSTIC CENTERS
    • AMBULATORY CARE CENTERS
    • OTHER END-USERS
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
    • COMPANY PROFILES
      • CANON MEDICAL SYSTEMS CORPORATION
      • CLARIUS
      • DAWEI MEDICAL
      • ESAOTE SPA
      • FUJIFILM HOLDINGS CORPORATION
      • GE HEALTHCARE
      • LANMAGE
      • LELTEK
      • MINDRAY MEDICAL INTERNATIONAL LIMITED
      • PHILIPS HEALTHCARE
      • SAMSUNG MEDISON CO LTD
      • SIEMENS HEALTHINEERS
      • TELEMED ULTRASOUND MEDICAL SYSTEMS
      • VIATOM TECHNOLOGY CO
      • ZONCARE

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – CARDIOVASCULAR ULTRASOUND

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 4: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DISPLAY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 5: GLOBAL BLACK AND WHITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL BLACK AND WHITE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL COLOR MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL COLOR MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL 2D MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL 2D MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL 3D/4D MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL 3D/4D MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL DOPPLER MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL DOPPLER MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL TRANSTHORACIC ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL TRANSTHORACIC ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL FETAL ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL FETAL ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL OTHER TYPES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL OTHER TYPES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 30: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 31: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 32: GLOBAL DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 33: GLOBAL AMBULATORY CARE CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: GLOBAL AMBULATORY CARE CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 36: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 37: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 38: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 39: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 40: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 41: LEADING PLAYERS OPERATING IN NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET

TABLE 42: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 43: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 44: LEADING PLAYERS OPERATING IN EUROPE CARDIOVASCULAR ULTRASOUND MARKET

TABLE 45: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 46: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 47: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET

TABLE 48: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 49: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 50: LEADING PLAYERS OPERATING IN REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET

TABLE 51: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 52: LIST OF PARTNERSHIPS & AGREEMENTS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY DISPLAY, IN 2021

FIGURE 8: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY BLACK AND WHITE, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY COLOR, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 11: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 2D, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY 3D/4D, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DOPPLER, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

FIGURE 15: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSTHORACIC ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY FETAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 17: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER TYPES, 2022-2030 (IN $ MILLION)

FIGURE 19: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 20: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY AMBULATORY CARE CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL CARDIOVASCULAR ULTRASOUND MARKET, BY OTHER END-USERS, 2022-2030 (IN $ MILLION)

FIGURE 24: NORTH AMERICA CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 25: UNITED STATES CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 26: CANADA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 27: EUROPE CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 28: UNITED KINGDOM CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 29: GERMANY CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 30: FRANCE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 31: ITALY CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: SPAIN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: NORDIC COUNTRIES CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: REST OF EUROPE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 36: CHINA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: JAPAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: INDIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 39: SOUTH KOREA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: INDONESIA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 41: SINGAPORE CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 42: TAIWAN CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 43: AUSTRALIA & NEW ZEALAND CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 44: REST OF ASIA-PACIFIC CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 45: REST OF WORLD CARDIOVASCULAR ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 46: LATIN AMERICA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 47: MIDDLE EAST & AFRICA CARDIOVASCULAR ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY DISPLAY
    • BLACK AND WHITE
    • COLOR
  2. MARKET BY TECHNOLOGY
    • 2D
    • 3D/4D
    • DOPPLER
  3. MARKET BY TYPE
    • TRANSTHORACIC ECHOCARDIOGRAPHY
    • FETAL ECHOCARDIOGRAPHY
    • TRANSESOPHAGEAL ECHOCARDIOGRAPHY
    • OTHER TYPES
  4. MARKET BY END-USER
    • HOSPITALS
    • DIAGNOSTIC CENTERS
    • AMBULATORY CARE CENTERS
    • OTHER END-USERS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions (FAQs):

    What is the worth of the global cardiovascular ultrasound market?

    The global cardiovascular ultrasound market was valued at $1477.29 million in 2021.

    Which is the fastest-growing country in the Asia-Pacific cardiovascular ultrasound market?

    Indonesia is the fastest-growing country in the Asia-Pacific cardiovascular ultrasound market, with a CAGR of 8.30%.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now